Prihlásiť sa Zaregistrujte sa zadarmo

Akcie v obehu spoločnosti ProMIS Neurosciences

Aká je hodnota metriky Akcie v obehu spoločnosti ProMIS Neurosciences?

Hodnota metriky Akcie v obehu spoločnosti ProMIS Neurosciences, Inc. je 409.472M 94.84%

Aká je definícia metriky Akcie v obehu?

Akcie v obehu (Shares float) je podiel akcií spoločnosti vlastnených verejnými investormi voči zablokovaným akciám (nie sú voľne v obehu).

Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded

The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.

Akcie v obehu spoločností v sektore Health Care sektor na OTC v porovnaní so spoločnosťou ProMIS Neurosciences

Čomu sa venuje spoločnosť ProMIS Neurosciences?

ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.

Firmy s metrikou akcie v obehu podobnou spoločnosti ProMIS Neurosciences



  • Hodnota metriky Akcie v obehu spoločnosti China High Speed Transmission Equipment Co je 408.823M 25.00%
  • Hodnota metriky Akcie v obehu spoločnosti Mobecom je 409.007M 72.31%
  • Hodnota metriky Akcie v obehu spoločnosti Buru je 409.279M 76.01%
  • Hodnota metriky Akcie v obehu spoločnosti Convenience Retail Asia je 409.283M 52.73%
  • Hodnota metriky Akcie v obehu spoločnosti RooLife Ltd je 409.365M 58.90%
  • Hodnota metriky Akcie v obehu spoločnosti CSMall je 409.440M 33.08%
  • Hodnota metriky Akcie v obehu spoločnosti ProMIS Neurosciences je 409.472M 94.84%
  • Hodnota metriky Akcie v obehu spoločnosti Waste Management je 409.566M 96.06%
  • Hodnota metriky Akcie v obehu spoločnosti IG Plc je 409.666M 94.92%
  • Hodnota metriky Akcie v obehu spoločnosti Alderan Resources je 409.707M 96.27%
  • Hodnota metriky Akcie v obehu spoločnosti Vikas Multicorp je 409.801M 61.76%
  • Hodnota metriky Akcie v obehu spoločnosti Bank of Maharashtra je 410.227M 6.25%
  • Hodnota metriky Akcie v obehu spoločnosti Senior Plc je 410.633M 97.91%